Are you A V Wegst?

Claim your profile

Publications (5)8.59 Total impact

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Two hundred and two patients with bone pain from metastatic cancer were treated with 40 microCi/kg of Sr-89. Patients were followed with pain diaries, records of medication taken, sleep patterns, serial bone scans and a Karnofsky Index. One hundred and thirty-seven patients with adequate followup survived at least 3 months, including 100 with prostate and 28 with breast carcinoma. Eighty of the 100 patients with prostate cancer responded, and 25 of the 28 breast cancer patients improved. Ten patients with prostate cancer and five with breast cancer became pain free. Little hematologic depression was noted. Sr-89 kinetic studies showed that strontium taken up in osteoblastic areas remained for 100 days. The tumor-to-marrow absorbed dose ratio was 10:1.
    Radiographics 04/1989; 9(2):271-81. · 2.79 Impact Factor
  • A V Wegst
    [Show abstract] [Hide abstract]
    ABSTRACT: The new tumoricidal radioactive agents being developed will require a careful estimate of radiation absorbed tumor and critical organ dose for each patient. Clinical methods will need to be developed using standard imaging or counting instruments to determine cumulated organ activities with tracer amounts before the therapeutic administration of the material. Standard MIRD dosimetry methods can then be applied.
    International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology 02/1987; 14(3):269-71.
  • [Show abstract] [Hide abstract]
    ABSTRACT: We have utilized 89Sr as palliative treatment for bone pain secondary to metastatic cancer in the skeleton of over 200 patients. The best results have been in patients with carcinoma of the prostate (80% response rate) and breast (89%). Results in a small number of patients with a variety of other cell types were not nearly as encouraging. Strontium-89 provides excellent palliation in the management of bone pain secondary to prostate and breast carcinoma.
    International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology 02/1987; 14(3):219-22.
  • [Show abstract] [Hide abstract]
    ABSTRACT: In the last decade diagnostic imaging departments, even those of moderate size, have experienced unprecedented growth. Much of this expansion can be attributed directly to technological developments, including systems for the acquisition of diagnostic images in digital format. In modern imaging departments, digital-based systems are quite common and are found across the specialities of nuclear medicine, ultrasound, transmission and emission computed tomography, and angiography. Nuclear magnetic resonance is the newest digital-based modality, and it appears destined to achieve its place in the diagnostic arsenal. These systems all have one trait in common, which is the topic of this paper. They offer the potential of increasing diagnostic accuracy by varying the methods used to process and display the acquired imaged data. We present the results of a nuclear medicine study designed to compare observer performance among five digital scintigraphic display modes. The observer's task was to detect artificially created lesions in brain scintigrams. Each mode is defined by a combination of an image processing function and a method of display. Using 40 trained observers, a receiver operating characteristic curve analysis was performed. The results support the use of color displays in nuclear medicine.
    Medical Decision Making 02/1983; 3(2):215-27. · 2.89 Impact Factor
  • A V Wegst, J E Goin, R G Robinson
    [Show abstract] [Hide abstract]
    ABSTRACT: Cumulated activity estimates for Tc-99m pertechnetate were determined using biodistribution data from pregnant and nonpregnant rats. The pregnant rats were studied at 13, 15, 17, 19, and 21 days gestation. The results indicate that maternal organ cumulated activities are not a simple function of gestational age. The organs into which Tc-99m pertechnetate enters through passive diffusion follow the pattern established by the blood, generally resulting in an increase from the 13th through the 17th day with a decrease on the 19th and 21st day. The organs dominated by active transport follow unique and different patterns. The fetal cumulated activity estimates increased exponentially with gestational age and the placental estimates increased linearly.
    Medical Physics 01/1983; 10(6):841-5. · 2.91 Impact Factor